Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) — Financial Flexibility Index
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) has a Financial Flexibility Index of -0.01x as of December 2025. Free cash flow of CN¥-44.49 Million (operating CF CN¥-149.12 Million minus capex CN¥104.63 Million) represents 0% of total liabilities (CN¥4.74 Billion). Check Hunan Dajiaweikang Pharmaceutical Indust (301126) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd across 7 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Hunan Dajiaweikang Pharmaceutical Indust.
Annual Financial Flexibility Index for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (2019–2025)
Year-by-year free cash flow to debt coverage for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd. Explore debt repayment capacity of Hunan Dajiaweikang Pharmaceutical Indust to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.01x | CN¥-44.49 Million | CN¥-149.12 Million | CN¥4.74 Billion | ▼ -119.2% |
| 2024 | 0.05x | CN¥211.18 Million | CN¥24.04 Million | CN¥4.33 Billion | ▼ -32.8% |
| 2023 | 0.07x | CN¥253.83 Million | CN¥27.13 Million | CN¥3.50 Billion | ▲ +153.8% |
| 2022 | -0.13x | CN¥-285.24 Million | CN¥-493.96 Million | CN¥2.11 Billion | ▼ -38.1% |
| 2021 | -0.10x | CN¥-128.52 Million | CN¥-161.81 Million | CN¥1.32 Billion | ▼ -7.5% |
| 2020 | -0.09x | CN¥-105.52 Million | CN¥-151.46 Million | CN¥1.16 Billion | ▼ -156.0% |
| 2019 | 0.16x | CN¥168.42 Million | CN¥135.91 Million | CN¥1.04 Billion | — |